We explored the effectiveness of magnesium sulfate (MS) in relieving low back pain (LBP) for patients who underwent iliac venous stenting. This study involved 97 patients, divided into two groups: one received MS infusion during their surgery, while the other did not.
Patients who received MS experienced significantly lower pain levels at all follow-up intervals. We found that, at 24 hours after surgery, those in the magnesium group consumed much less tramadol—a common pain medication—compared to the control group. Additionally, the need for extra pain relief was lower among those who received magnesium.
Importantly, the side effects like nausea and vomiting were similar in both groups, indicating that magnesium can be a safe option for pain management after this type of surgery. Overall, the findings suggest that magnesium sulfate not only alleviates pain but also reduces reliance on opioids, making it a valuable treatment for postoperative care.
Read More
Magnesium therapy aids back painA double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component.
Explores magnesium's combined benefits
We conducted a double-blind study to evaluate the effectiveness of magnesium therapy for chronic low back pain that has a neuropathic component. Our research involved 80 patients, all of whom were already engaged in physical therapy and taking medications like anticonvulsants and antidepressants.
Among the participants, we divided them into two groups: one group received a placebo for six weeks, while the other group was treated with a two-week intravenous magnesium infusion followed by four weeks of oral magnesium supplements.
The results were promising for those in the magnesium group. By the end of the study, their pain intensity decreased significantly, with scores dropping from an average of 7.5 to 4.7 over six months. Additionally, we observed notable improvements in their lumbar spine mobility, suggesting that magnesium therapy could be beneficial for those suffering from this type of chronic pain.
Overall, our findings indicate that sequential intravenous and oral magnesium treatment can effectively ease pain and enhance mobility in individuals with refractory low back pain featuring a neuropathic aspect.
Read More
We investigated whether supplementation with alkaline minerals could ease chronic low back pain. In a study with 82 participants, those who took a lactose-based alkaline multimineral supplement for four weeks reported a significant 49% reduction in pain scores.
We also noted an increase in blood buffering capacity and pH, indicating an improved acid-base balance. Although intracellular magnesium levels increased, plasma magnesium slightly decreased, suggesting that while the supplementation helped alleviate pain, it didn't significantly impact magnesium levels overall.
This study highlights the potential benefits of correcting acid-base balance to reduce low back pain symptoms.
Read More
Magnesium shows promise for IVDDROS-responsive magnesium-containing microspheres for antioxidative treatment of intervertebral disc degeneration.
Moderate relevance to magnesium treatment
We explored the potential of magnesium-containing microspheres to help manage intervertebral disc degeneration (IVDD), a condition often linked with back pain. This innovative treatment focuses on using microspheres that respond to reactive oxygen species, which are indicators of oxidative stress often seen in IVDD. By targeting these harmful agents, we aimed to reduce the associated inflammation and pain.
The microspheres, composed of a polymer shell and a magnesium core, work by releasing hydrogen gas in response to oxidative conditions, which can help neutralize damaging free radicals in the body. We observed significant improvements in a rat model of disc degeneration, which included less damage to the disc structure, reduced cell death, and overall better disc health.
The results of this study highlight magnesium's role as a key component in enhancing the antioxidative capacity of the treatment. This not only mitigates the effects of IVDD but also supports the idea that antioxidant therapies may hold promise for alleviating back pain. Importantly, we noted that this approach showed strong biocompatibility and minimal toxicity, making it a potential option for future clinical applications.
Read More
Magnesium and back pain reliefGreen exercise and mg-ca-SO thermal balneotherapy for the treatment of non-specific chronic low back pain: a randomized controlled clinical trial.
Moderate effectiveness observed
We conducted a study to explore how magnesium treatment and mountain hiking might alleviate non-specific chronic low back pain (nscLBP). In this randomized controlled trial, we divided eighty participants into three groups: one engaged in green exercise (mountain hiking), another combined hiking with magnesium-calcium-sulfate thermal baths, and a control group received no treatment.
Our findings showed significant improvements in back pain among participants who participated in hiking and bathing in thermal water compared to those who didn't receive any intervention. However, it is important to note that we cannot isolate the benefits of magnesium treatment since it was combined with the physical activity of hiking. Therefore, while magnesium's involvement is notable, its individual impact remains unclear from our results.
This study highlights the promise of integrating physical activities like mountain hiking alongside therapeutic treatments for managing chronic back pain. Future research should delve deeper into the long-term effects of such multi-faceted therapies to fully understand the role of magnesium in this context.
Read More